Thomas J. Dodd
11Patents
5h-index
1Co-inventors
45Inventor score
Filing activity: Oct 17, 1997 → Jan 6, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5919816A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 48 | Expired |
| US6066668A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 11 | Expired |
| US6057361A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 10 | Expired |
| US6066645A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 8 | Expired |
| US6046159A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 5 | Expired |
| US6040294A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 4 | Expired |
| US6043249A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 3 | Expired |
| US6046234A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 3 | Expired |
| US6048849A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 3 | Expired |
| US6040312A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 3 | Expired |
| US6040304A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.